Mechano Growth Factor (MGF)
Muscle-damage-responsive IGF-1 splice variant. Very short half-life, post-workout timing critical.
- Half-life
- 6 min
- Out of system
- ~1 h
- Route
- Subcutaneous
- Level
- Advanced
Very short-acting — protocols dose 1–2× a day. After the last dose, roughly 97% has cleared in ~1 h (five half-lives) — the window that matters for washouts, bloodwork and surgery.
What Mechano Growth Factor (MGF) is used for
- Muscle-damage-responsive IGF-1 splice variant
- Used post-workout for local repair signaling
How it's typically used
Research range: ~200 mcg subcutaneous post-workout (local).
What to watch for
- Very short half-life — timing-sensitive, much overstated
- Theoretical cancer-growth concern
- Research-only; minimal human data
About Performance & GH
- What they are
- Growth-hormone secretagogues and related performance compounds. Rather than supplying GH, they push your pituitary to release more of its own in a pulse.
- How they're run
- Subcutaneous injection, most often at night on an empty stomach so the pulse lands with natural sleep-driven GH release.
- What to watch
- Water retention, tingling hands, and hunger swings are the common early signs. Raising GH raises IGF-1 — worth tracking on bloodwork, and a reason to avoid these with any cancer history.
Full guide
Mechano Growth Factor (MGF): What the Splice Variant Story Actually Says
A pragmatic tracking guide for MGF, the muscle-damage-responsive splice variant of IGF-1.
Other performance & gh
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.